The Lancet Global Health, February 2022, Volume 10, Issue 2, Pages e154-e297
Read the current issue of The Lancet Global Health, a monthly open access journal publishing robustly designed original research on all aspects of global health
Related Articles
Peripheral amyloid-β clearance mediates cognitive impairment in non-alcoholic fatty liver disease
LRP-1 mediates the adverse effect of NAFLD on peripheral Aβ clearance, thereby contributing to cerebral Aβ accumulation and cognitive impairment in NAFLD.
Observation versus screening spinal MRI and pre-emptive treatment for spinal cord compression in patients with castration-resistant prostate cancer and spinal metastases in the UK (PROMPTS): an open-label, randomised, controlled, phase 3 trial
Despite the substantial incidence of rSCC detected in the intervention group, the rate of cSCC in both groups was low at a median of 22…
Offline: It is time to take cancer more seriously
The Lancet has published two Commissions in 2024 addressing the commonest cancers among men and women: prostate cancer (led by Nicholas James) and breast cancer…
Earth Day: time for transformational change
On April 22, the 54th annual Earth Day will continue endeavours to “diversify, educate and activate the environmental movement worldwide”. Part of Earth Day’s ongoing…
Offline: It is time to take cancer more seriously
The Lancet has published two Commissions in 2024 addressing the commonest cancers among men and women: prostate cancer (led by Nicholas James) and breast cancer…
Blood transcriptomic analyses reveal persistent SARS-CoV-2 RNA and candidate biomarkers in post-COVID-19 condition
With an estimated 65 million individuals affected by post-COVID-19 condition (also known as long COVID),1 non-invasive biomarkers are direly needed to guide clinical management. To…
Responsible and evidence-based AI: 5 years on
“The answer to our current health crisis is AI; AI is better than doctors and we should be using it now.”
Blood transcriptomic analyses reveal persistent SARS-CoV-2 RNA and candidate biomarkers in post-COVID-19 condition
With an estimated 65 million individuals affected by post-COVID-19 condition (also known as long COVID),1 non-invasive biomarkers are direly needed to guide clinical management. To…
Endocrine health in survivors of adult-onset cancer
Long-term survivors of cancer (ie, the patient who is considered cured or for whom the disease is under long-term control and unlikely to recur) are…
Cardiovascular risk in young people with childhood onset systemic lupus erythematosus
Since 1940, epidemiologists, clinicians, and scientists promoted increased awareness of the crucial importance of promoting preventive strategies for minimising the risk of poor health later…
